EBITDA impact
Reductions in healthcare spend fall almost entirely to the bottom line. We size the opportunity before recommending anything.
For CFOs & Finance Leaders
You would never approve a seven-figure vendor relationship with no cost model, no performance data and no competitive review. Yet that is how most healthcare programs are renewed. I bring financial discipline to the line item that resists it.
The financial lens
Every finding is expressed the way finance evaluates decisions: dollars, timing, probability and downside.
Reductions in healthcare spend fall almost entirely to the bottom line. We size the opportunity before recommending anything.
Spread pricing, misallocated rebates, redundant vendor fees, stop-loss leveraging and plan design drift — quantified line by line.
Move from a renewal number handed to you in October to a defensible multi-year cost model you build in advance.
CAA 2021 made plan sponsors accountable for reasonable fees and vendor transparency. We document that you met the standard.
Funding, network and pharmacy purchasing evaluated as procurement decisions, with real alternatives priced.
Written scope of services, measurable deliverables and a scorecard for every partner you pay — including your broker.
Outcomes
A diagnostic of this scope would typically be a paid $2,500–$5,000 engagement. It is offered complimentary to qualified employers.
Request a Healthcare Cost AssessmentA 20-minute conversation is enough to tell whether there is a material opportunity in your program.
Request a Healthcare Cost Assessment